Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2015 4
2016 11
2017 5
2018 5
2019 3
2020 2
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature.
Guglielmo P, Alongi P, Baratto L, Abenavoli E, Buschiazzo A, Celesti G, Conte M, Filice R, Gorica J, Jonghi-Lavarini L, Lanzafame H, Laudicella R, Librando M, Linguanti F, Mattana F, Miceli A, Olivari L, Piscopo L, Romagnolo C, Santo G, Vento A, Volpe F, Evangelista L. Guglielmo P, et al. Among authors: buschiazzo a. Life (Basel). 2023 Aug 28;13(9):1821. doi: 10.3390/life13091821. Life (Basel). 2023. PMID: 37763225 Free PMC article. Review.
Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics.
Liberini V, Laudicella R, Balma M, Nicolotti DG, Buschiazzo A, Grimaldi S, Lorenzon L, Bianchi A, Peano S, Bartolotta TV, Farsad M, Baldari S, Burger IA, Huellner MW, Papaleo A, Deandreis D. Liberini V, et al. Among authors: buschiazzo a. Eur Radiol Exp. 2022 Jun 15;6(1):27. doi: 10.1186/s41747-022-00282-0. Eur Radiol Exp. 2022. PMID: 35701671 Free PMC article. Review.
The Role of Theragnostics in Breast Cancer: A Systematic Review of the Last 12 Years.
Balma M, Liberini V, Buschiazzo A, Racca M, Rizzo A, Nicolotti DG, Laudicella R, Quartuccio N, Longo M, Perlo G, Terreno E, Abgral R, William Huellner M, Papaleo A, Deandreis D. Balma M, et al. Among authors: buschiazzo a. Curr Med Imaging. 2023;19(8):817-831. doi: 10.2174/1573405619666230216114748. Curr Med Imaging. 2023. PMID: 36797602
Enhancement of Tumor Homing by Chemotherapy-Loaded Nanoparticles.
Ponzoni M, Curnis F, Brignole C, Bruno S, Guarnieri D, Sitia L, Marotta R, Sacchi A, Bauckneht M, Buschiazzo A, Rossi A, Di Paolo D, Perri P, Gori A, Sementa AR, Emionite L, Cilli M, Tamma R, Ribatti D, Pompa PP, Marini C, Sambuceti G, Corti A, Pastorino F. Ponzoni M, et al. Among authors: buschiazzo a. Small. 2018 Nov;14(45):e1802886. doi: 10.1002/smll.201802886. Epub 2018 Oct 7. Small. 2018. PMID: 30294852
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study.
Bianchi A, De Rimini ML, Sciuto R, Annovazzi A, Di Traglia S, Bauckneht M, Lanfranchi F, Morbelli S, Nappi AG, Ferrari C, Rubini G, Panareo S, Urso L, Bartolomei M, D'Arienzo D, Valente T, Rossetti V, Caroli P, Matteucci F, Aricò D, Bombaci M, Caponnetto D, Bertagna F, Albano D, Dondi F, Gusella S, Spimpolo A, Carriere C, Balma M, Buschiazzo A, Gallicchio R, Storto G, Ruffini L, Scarlattei M, Baldari G, Cervino AR, Cuppari L, Burei M, Trifirò G, Brugola E, Zanini CA, Alessi A, Fuoco V, Seregni E, Deandreis D, Liberini V, Moreci AM, Ialuna S, Pulizzi S, Evangelista L. Bianchi A, et al. Among authors: buschiazzo a. Cancer Biother Radiopharm. 2023 May;38(4):256-267. doi: 10.1089/cbr.2022.0092. Epub 2023 Apr 25. Cancer Biother Radiopharm. 2023. PMID: 37098169
Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review.
Balma M, Liberini V, Racca M, Laudicella R, Bauckneht M, Buschiazzo A, Nicolotti DG, Peano S, Bianchi A, Albano G, Quartuccio N, Abgral R, Morbelli SD, D'Alessandria C, Terreno E, Huellner MW, Papaleo A, Deandreis D. Balma M, et al. Among authors: buschiazzo a. Front Med (Lausanne). 2022 Apr 12;9:881551. doi: 10.3389/fmed.2022.881551. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35492341 Free PMC article.
FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature.
Guglielmo P, Alongi P, Baratto L, Conte M, Abenavoli EM, Buschiazzo A, Celesti G, Dondi F, Filice R, Gorica J, Jonghi-Lavarini L, Laudicella R, Librando M, Linguanti F, Mattana F, Miceli A, Olivari L, Piscopo L, Santo G, Volpe F, Evangelista L. Guglielmo P, et al. Among authors: buschiazzo a. Cancers (Basel). 2024 Feb 19;16(4):839. doi: 10.3390/cancers16040839. Cancers (Basel). 2024. PMID: 38398230 Free PMC article. Review.
Prostate-Specific Membrane Antigen Positron Emission Tomography Oncological Applications beyond Prostate Cancer in Comparison to Other Radiopharmaceuticals.
Miceli A, Liberini V, Pepe G, Dondi F, Vento A, Jonghi Lavarini L, Celesti G, Gazzilli M, Serani F, Guglielmo P, Buschiazzo A, Filice R, Alongi P, Laudicella R, Santo G. Miceli A, et al. Among authors: buschiazzo a. Diagnostics (Basel). 2024 May 13;14(10):1002. doi: 10.3390/diagnostics14101002. Diagnostics (Basel). 2024. PMID: 38786300 Free PMC article. Review.
Ischemia-reperfusion damage is attenuated by GQ-11, a peroxisome proliferator-activated receptor (PPAR)-α/γ agonist, after aorta clamping in rats.
Cavalcante Silva J, Bavestrello M, Gazzola V, Spinella G, Pane B, Grasselli E, Demori I, Canesi L, Emionite L, Cilli M, Buschiazzo A, Sambuceti G, Pitta IR, Pitta MG, Perego P, Palombo D, Abdalla DSP. Cavalcante Silva J, et al. Among authors: buschiazzo a. Life Sci. 2022 May 15;297:120468. doi: 10.1016/j.lfs.2022.120468. Epub 2022 Mar 11. Life Sci. 2022. PMID: 35288175
36 results